DRY AGE-RELATED MACULAR DEGENERATION
Clinical trials for DRY AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new DRY AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for DRY AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy injection aims to treat dry AMD
Disease control CompletedThis study tests the safety of a single injection of PST-611, a DNA-based therapy, in people aged 50 and older with dry age-related macular degeneration (AMD). The therapy is designed to make the eye produce a protein that may protect against vision loss. Participants receive one…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Eyevensys • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could light therapy help save sight in dry macular degeneration?
Disease control CompletedThis study investigates whether a non-invasive light treatment called photobiomodulation can improve vision and slow vision loss in people with dry age-related macular degeneration (AMD). Participants receive either active light therapy or a sham (inactive) treatment over 12 mont…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: LumiThera, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Bionic implant shows promise for restoring sight in dry AMD
Disease control CompletedThis study tested a tiny implant called the PRIMA Bionic Vision System in 5 people with advanced dry age-related macular degeneration who had lost central vision. The implant is placed under the retina and uses electrical stimulation to replace damaged light-sensing cells. The go…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Science Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Blood-Based injection shows promise for slowing dry AMD
Disease control CompletedThis study tested whether injecting a concentrated form of a patient's own blood, called platelet-rich plasma (PRP), into the eye could slow the progression of advanced dry age-related macular degeneration (AMD). Fourteen people with advanced dry AMD received three PRP injections…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC